United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp at Credit Suisse Healthcare Conference Transcript

Nov 08, 2022 / 08:50PM GMT
Release Date Price: €259.8 (-1.78%)
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Perfect. Welcome, everyone, to Annual Healthcare Conference at Credit Suisse. I'm Tiago Fauth. I'm one of the lead analyst in the biotech franchise here. We're joined today by United Therapeutics. So Pat and Dewey. So thank you very much for joining us.

Patrick Poisson
United Therapeutics Corporation - Executive VP of Technical Operations

Thank you.

Dewey Steadman
United Therapeutics Corporation - Head of IR

Thank you for having us. Can I mention really quick that Pat and I may make forward-looking statements in our presentation today. And we caution you to review the risks and uncertainties associated with these disclosures in our SEC filings, particularly Forms 10-K and 10-Q that are available on the SEC website. Thank you.

Questions & Answers

Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

There you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot